GRAIL, Inc. $GRAL Shares Sold by Deutsche Bank AG

Deutsche Bank AG lessened its holdings in GRAIL, Inc. (NASDAQ:GRAL) by 68.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,846 shares of the company’s stock after selling 38,216 shares during the quarter. Deutsche Bank AG owned approximately 0.05% of GRAIL worth $456,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in GRAL. State of Tennessee Department of Treasury bought a new stake in shares of GRAIL during the fourth quarter valued at about $28,000. Caldwell Sutter Capital Inc. purchased a new position in GRAIL during the first quarter valued at approximately $28,000. KBC Group NV boosted its position in GRAIL by 187.7% during the first quarter. KBC Group NV now owns 1,430 shares of the company’s stock valued at $37,000 after purchasing an additional 933 shares during the last quarter. S.A. Mason LLC lifted its stake in GRAIL by 50.1% in the first quarter. S.A. Mason LLC now owns 1,499 shares of the company’s stock valued at $38,000 after acquiring an additional 500 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in GRAIL in the fourth quarter worth $41,000.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group raised their target price on GRAIL from $32.00 to $43.00 and gave the company a “buy” rating in a report on Wednesday, May 14th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, GRAIL presently has an average rating of “Hold” and a consensus price target of $31.50.

GRAIL Trading Down 1.3%

GRAL stock opened at $33.63 on Thursday. GRAIL, Inc. has a 1-year low of $12.33 and a 1-year high of $63.99. The firm has a market cap of $1.21 billion, a P/E ratio of -2.57 and a beta of 3.26. The business’s 50 day moving average is $38.56 and its 200-day moving average is $36.37.

GRAIL (NASDAQ:GRAL) last announced its earnings results on Tuesday, August 12th. The company reported ($3.18) EPS for the quarter, missing the consensus estimate of ($3.14) by ($0.04). The business had revenue of $35.54 million during the quarter, compared to analyst estimates of $37.57 million. GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%. Sell-side analysts forecast that GRAIL, Inc. will post -15.15 EPS for the current year.

Insiders Place Their Bets

In other news, major shareholder Chun R. Ding sold 339,800 shares of the stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $49.53, for a total value of $16,830,294.00. Following the transaction, the insider owned 3,305,055 shares of the company’s stock, valued at $163,699,374.15. This represents a 9.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Aaron Freidin sold 8,000 shares of the firm’s stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $38.93, for a total value of $311,440.00. Following the sale, the chief financial officer directly owned 286,020 shares in the company, valued at $11,134,758.60. The trade was a 2.72% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 361,694 shares of company stock valued at $17,780,266. 1.85% of the stock is currently owned by corporate insiders.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.